Related Experiment Video

Updated: May 29, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions

Junichi Kitanaka1, Nobue Kitanaka, Motohiko Takemura

  • 1Department of Pharmacology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.

Drug Target Insights
|September 9, 2011
PubMed

Insights

Monoamine oxidase (MAO) inhibitors, like clorgyline, show promise in treating methamphetamine (METH) abuse by modulating brain chemistry and reducing METH-induced behaviors. Further research into MAO inhibitors is crucial for developing effective METH addiction treatments.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Addiction Research

Background:

  • Methamphetamine (METH) abuse presents a significant global health challenge with no current effective pharmacological treatments.
  • Monoamine oxidase (MAO) is an intracellular target protein implicated in regulating brain monoaminergic tone and modulating METH-induced behaviors.
  • METH's effects on motor activity, stereotypy, and sensitization are linked to brain monoaminergic transmission.

Purpose of the Study:

  • To review current research on the potential of monoamine oxidase (MAO) inhibitors as a treatment strategy for methamphetamine (METH) abuse.
  • To explore the mechanisms by which MAO inhibitors influence METH's actions and associated behavioral abnormalities.

Main Methods:

  • Review of existing scientific literature on METH abuse and the effects of MAO inhibitors.
  • Analysis of studies investigating the impact of MAO inhibitors, specifically clorgyline (an MAO-A inhibitor), on METH-induced behaviors in animal models.
  • Examination of associated changes in monoaminergic activity, including striatal serotonergic and dopaminergic transmission.

Main Results:

  • The irreversible MAO-A inhibitor clorgyline effectively blocks METH-induced hyperlocomotion and behavioral sensitization in rodents.
  • MAO inhibitor effects on METH action involve altered striatal serotonergic transmission and increased dopaminergic tone.
  • Some observed effects of MAO inhibitors suggest mechanisms of action in METH abuse that are independent of MAO activity.

Conclusions:

  • MAO inhibitors represent a potential therapeutic avenue for treating methamphetamine (METH) abuse.
  • The complex mechanisms of MAO inhibitors in METH abuse warrant further investigation.
  • Continued research into MAO inhibitors could lead to the development of novel treatments for METH addiction.
Keywords:
5-HTbehavioral sensitizationclorgylinehyperlocomotionmethamphetaminemonoamine oxidasemonoamine turnoverselegilinestereotypystriatum

More Related Videos

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry07:30

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry

Published on: November 21, 2012

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

Related Concept Videos

Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...